![Ken Macnamara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Kenneth Macnamara is the founder of Trogenix Ltd., founded in 2023, holding the title of Chief Executive Officer & Director.
Dr. Macnamara currently holds the position of Chief Operating Officer at AskBio Inc. since 2019 and Chief Operating Officer at Synpromics Ltd.
Posizioni attive di Ken Macnamara
| Società | Posizione | Inizio |
|---|---|---|
Synpromics Ltd.
 Synpromics Ltd. Chemicals: SpecialtyProcess Industries Develops and commercializes synthetic promoters to control gene expressions and regulations | Direttore operativo | - |
AskBio Inc.
 AskBio Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Direttore operativo | 01/01/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
2
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
AskBio Inc.
AskBio Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Health Technology |
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Develops and commercializes synthetic promoters to control gene expressions and regulations | Process Industries |
